Synthesis and SAR study of novel anticancer and antimicrobial naphthoquinone amide derivatives T Sreelatha, S Kandhasamy, R Dinesh, S Shruthy, S Shweta, D Mukesh, ... Bioorganic & medicinal chemistry letters 24 (15), 3647-3651, 2014 | 89 | 2014 |
Emerging nanoproteomics approaches for disease biomarker detection: A current perspective S Ray, PJ Reddy, S Choudhary, D Raghu, S Srivastava Journal of proteomics 74 (12), 2660-2681, 2011 | 83 | 2011 |
Mutant p53 drives cancer by subverting multiple tumor suppression pathways S Haupt, D Raghu, Y Haupt Frontiers in oncology 6, 12, 2016 | 77 | 2016 |
Control of lymphocyte fate, infection, and tumor immunity by TCF-1 D Raghu, HH Xue, LA Mielke Trends in immunology 40 (12), 1149-1162, 2019 | 73 | 2019 |
Serum proteome analysis of vivax malaria: An insight into the disease pathogenesis and host immune response S Ray, KS Kamath, R Srivastava, D Raghu, K Gollapalli, R Jain, SV Gupta, ... Journal of proteomics 75 (10), 3063-3080, 2012 | 55 | 2012 |
TCF-1 limits the formation of Tc17 cells via repression of the MAF–RORγt axis LA Mielke, Y Liao, EB Clemens, MA Firth, B Duckworth, Q Huang, ... Journal of Experimental Medicine 216 (7), 1682-1699, 2019 | 54 | 2019 |
Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP PJ Paul, D Raghu, AL Chan, T Gulati, L Lambeth, E Takano, MJ Herold, ... Oncogene 35 (48), 6235-6245, 2016 | 39 | 2016 |
MDM4 is a rational target for treating breast cancers with mutant p53 PJ Miranda, D Buckley, D Raghu, JMB Pang, EA Takano, ... The Journal of Pathology 241 (5), 661-670, 2017 | 37 | 2017 |
E6AP promotes prostate cancer by reducing p27 expression D Raghu, PJ Paul, T Gulati, S Deb, C Khoo, A Russo, E Gallo, G Blandino, ... Oncotarget 8 (26), 42939, 2017 | 36 | 2017 |
Menadione (Vitamin K3) induces apoptosis of human oral cancer cells and reduces their metastatic potential by modulating the expression of epithelial to mesenchymal transition … S Suresh, D Raghu, D Karunagaran Asian Pacific Journal of Cancer Prevention 14 (9), 5461-5465, 2013 | 36 | 2013 |
Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells D Raghu, D Karunagaran Journal of natural products 77 (5), 1130-1134, 2014 | 24 | 2014 |
Proteotranscriptomic measurements of E6-associated protein (E6AP) targets in DU145 prostate cancer cells T Gulati, C Huang, F Caramia, D Raghu, PJ Paul, RJA Goode, SP Keam, ... Molecular & Cellular Proteomics 17 (6), 1170-1183, 2018 | 18 | 2018 |
p53 calls upon CIA (Calcium Induced Apoptosis) to counter stress S Haupt, D Raghu, Y Haupt Frontiers in oncology 5, 57, 2015 | 16 | 2015 |
Crosstalk between epithelium, myeloid and innate lymphoid cells during gut homeostasis and disease S Ghilas, R O’Keefe, LA Mielke, D Raghu, M Buchert, M Ernst Frontiers in Immunology 13, 944982, 2022 | 7 | 2022 |
Targeting MDM4 as a novel therapeutic approach in prostate cancer independent of p53 status JO Mejía-Hernández, D Raghu, F Caramia, N Clemons, K Fujihara, ... Cancers 14 (16), 3947, 2022 | 5 | 2022 |
Cytotoxic effects of polysaccharides isolated from Emilia sonchifolia in cervical cancer cell line TG Pillai, D Raghu, D Karunagaran Cancer Rep. Rev 1 (6), 1-4, 2017 | 3 | 2017 |
cellCounts: an R function for quantifying 10x Chromium single-cell RNA sequencing data Y Liao, D Raghu, B Pal, LA Mielke, W Shi Bioinformatics 39 (7), btad439, 2023 | 2 | 2023 |
TCF-1 is a critical regulator of intraepithelial lymphocytes in colorectal carcinoma MH Yakou, S Ghilas, K Tran, Y Liao, S Afshar-Sterle, A Kumari, K Schmid, ... Cancer Research 84 (6_Supplement), 2698-2698, 2024 | | 2024 |
1038 T cell factor 1 (TCF-1) is a molecular checkpoint in colorectal carcinoma γδ T cell immunity M Yakou, S Ghilas, K Tran, Y Liao, S Afshar-Sterle, A Kumari, K Schmid, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023 | | 2023 |
TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma MH Yakou, S Ghilas, K Tran, Y Liao, S Afshar-Sterle, A Kumari, K Schmid, ... Science Immunology 8 (88), eadf2163, 2023 | | 2023 |